Published in Blood on November 15, 2001
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia (2009) 2.50
Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia (2008) 2.29
T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells. Proc Natl Acad Sci U S A (2002) 1.74
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell (2009) 1.73
Dysfunctional T regulatory cells in multiple myeloma. Blood (2005) 1.72
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing. Blood (2015) 1.48
Dendritic cells in the cancer microenvironment. J Cancer (2012) 1.40
Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood (2005) 1.21
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol (2004) 1.16
Tumor associated regulatory dendritic cells. Semin Cancer Biol (2012) 1.08
Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma. Leukemia (2013) 1.08
Myeloid-derived suppressor cells as therapeutic target in hematological malignancies. Front Oncol (2014) 1.04
Molecular action of lenalidomide in lymphocytes and hematologic malignancies. Adv Hematol (2012) 1.01
Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma. Adv Hematol (2012) 1.00
Cellular mechanisms of multiple myeloma bone disease. Clin Dev Immunol (2013) 0.96
Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma. Clin Exp Immunol (2006) 0.94
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma. Cancer Immunol Immunother (2011) 0.91
Immunotherapy using dendritic cells against multiple myeloma: how to improve? Clin Dev Immunol (2012) 0.91
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma. J Transl Med (2012) 0.89
Dendritic cell defects in patients with cancer: mechanisms and significance. Breast Cancer Res (2006) 0.89
Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions. Clin Dev Immunol (2012) 0.88
Adoptive T-cell therapy for B-cell malignancies. Expert Rev Hematol (2009) 0.88
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis. Expert Rev Mol Diagn (2010) 0.87
Cancer vaccines: on the threshold of success. Expert Opin Emerg Drugs (2008) 0.87
Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy. Cancer J (2011) 0.86
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host. Biology (Basel) (2013) 0.86
T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy. Cancer Immunol Res (2015) 0.86
Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. Clin Exp Immunol (2014) 0.86
Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system. Mediators Inflamm (2012) 0.85
Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes. Clin Dev Immunol (2012) 0.84
Cellular immunotherapy using dendritic cells against multiple myeloma. Korean J Hematol (2012) 0.83
Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? Oncologist (2011) 0.82
Dendritic cell defects in the colorectal cancer. Hum Vaccin Immunother (2014) 0.82
Development of Novel Immunotherapies for Multiple Myeloma. Int J Mol Sci (2016) 0.82
Immune therapies. Hematol Oncol Clin North Am (2007) 0.81
Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma. Front Immunol (2014) 0.79
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma. Oncoimmunology (2012) 0.79
Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells. J Immune Based Ther Vaccines (2010) 0.78
Lessons learnt from evidence-based approach of using chinese herbal medicines in liver cancer. Evid Based Complement Alternat Med (2013) 0.78
Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche. J Leukoc Biol (2017) 0.77
Drug-induced modulation of T lymphocytes as a potential mechanism of susceptibility to infections in patients with multiple myeloma during bortezomib therapy. Cell Biochem Biophys (2015) 0.77
Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies. Blood (2016) 0.76
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties. Oncotarget (2017) 0.76
Mechanism of humoral and cellular immune modulation provided by porcine sertoli cells. J Korean Med Sci (2008) 0.75
Ensemble learning for prediction of the bioactivity capacity of herbal medicines from chromatographic fingerprints. BMC Bioinformatics (2015) 0.75
CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation. Mediators Inflamm (2013) 0.75
Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies. J Immunol Res (2017) 0.75
Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial. Clin Lymphoma Myeloma Leuk (2017) 0.75
Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities. J Mol Med (Berl) (2015) 0.75
Collagen scaffold microenvironments modulate cell lineage commitment for differentiation of bone marrow cells into regulatory dendritic cells. Sci Rep (2017) 0.75
Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function. PLoS One (2015) 0.75
Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells. Genes Cancer (2017) 0.75
Prediction of Radix Astragali Immunomodulatory Effect of CD80 Expression from Chromatograms by Quantitative Pattern-Activity Relationship. Biomed Res Int (2017) 0.75
Immune checkpoint blockade for hematologic malignancies: a review. Stem Cell Investig (2017) 0.75
The phylogeny of prokaryotes. Science (1980) 24.57
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Ecology. Synthesizing U.S. river restoration efforts. Science (2005) 7.26
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
In vivo localization of DNA sequences and visualization of large-scale chromatin organization using lac operator/repressor recognition. J Cell Biol (1996) 6.78
Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Mol Biol Cell (1997) 5.47
Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function. J Cell Biol (1997) 4.54
The use of Xenopus egg extracts to study mitotic spindle assembly and function in vitro. Methods Cell Biol (1999) 4.31
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J (1987) 3.81
Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J (1988) 3.81
Genetic influences on osteoarthritis in women: a twin study. BMJ (1996) 3.70
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Import of proteins into mitochondria. The precursor of cytochrome c1 is processed in two steps, one of them heme-dependent. J Biol Chem (1982) 3.26
Studies on the chymotryptic digestion of myosin. Effects of divalent cations on proteolytic susceptibility. J Mol Biol (1977) 3.02
Conservation. Challenges to the future conservation of the Antarctic. Science (2012) 3.01
The Defeat Depression Campaign: psychiatry in the public arena. Am J Psychiatry (1997) 3.00
Head injuries in three Scottish neurosurgical units. Scottish head injury management study. Br Med J (1979) 2.93
A quantitative description of short-term plasticity at excitatory synapses in layer 2/3 of rat primary visual cortex. J Neurosci (1997) 2.79
Dynamics of centromeres during metaphase-anaphase transition in fission yeast: Dis1 is implicated in force balance in metaphase bipolar spindle. Mol Biol Cell (1998) 2.79
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Revised radiation doses for typical X-ray examinations. Report on a recent review of doses to patients from medical X-ray examinations in the UK by NRPB. National Radiological Protection Board. Br J Radiol (1997) 2.71
The role of the general dental practitioner in detection and prevention of oral cancer: a review of the literature. Dent Update (2000) 2.67
Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J (1978) 2.65
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease. J Clin Microbiol (1995) 2.52
Human actin depolymerizing factor mediates a pH-sensitive destruction of actin filaments. Biochemistry (1993) 2.49
Anaerobic and aerobic metabolism of diverse aromatic compounds by the photosynthetic bacterium Rhodopseudomonas palustris. Appl Environ Microbiol (1988) 2.46
Studies on intercellular LETS glycoprotein matrices. Cell (1978) 2.44
Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med (2003) 2.40
Imported mitochondrial proteins cytochrome b2 and cytochrome c1 are processed in two steps. Proc Natl Acad Sci U S A (1982) 2.39
Recombination breakpoints in the human beta-globin gene cluster. Blood (1998) 2.38
The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur Respir J (2005) 2.37
Identification of a region in segment 1 of gelsolin critical for actin binding. EMBO J (1990) 2.36
Changes in public attitudes to depression during the Defeat Depression Campaign. Br J Psychiatry (1998) 2.22
Dibiphytanyl ether lipids in nonthermophilic crenarchaeotes. Appl Environ Microbiol (1998) 2.20
Uptake of benzoate by Rhodopseudomonas palustris grown anaerobically in light. J Bacteriol (1986) 2.20
A measurement process for evaluating clinical teachers in internal medicine. CMAJ (1993) 2.19
Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: mechanisms of endocytosis. J Gen Microbiol (1984) 2.18
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med (1996) 2.18
The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol Rev (1997) 2.16
Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen (2000) 2.15
Do genealogical patterns in purple photosynthetic bacteria reflect interspecific gene transfer? Nature (1980) 2.08
Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol (2007) 2.06
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood (1996) 2.06
Caudal tramadol for postoperative analgesia in pediatric hypospadias surgery. Br J Anaesth (1997) 2.05
Hemodynamic consequences of high- and low-pressure capnoperitoneum during laparoscopic cholecystectomy. Surg Endosc (1999) 2.04
HIV gp120 receptors on human dendritic cells. Blood (2001) 2.03
Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem (1999) 2.01
Molecular subtyping scheme for serotypes HS1 and HS4 of Campylobacter jejuni. J Clin Microbiol (1995) 2.01
Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study. BJOG (2013) 2.00
Fragile X premutation screening in women with premature ovarian failure. Hum Reprod (1998) 1.99
Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis. J Cell Biol (1989) 1.97
Microscopic image analysis for quantitative measurement and feature identification of normal and cancerous colonic mucosa. IEEE Trans Inf Technol Biomed (1998) 1.95
Accuracy of electoral registers and Family Practitioner Committee lists for population studies of the very elderly. J Epidemiol Community Health (1989) 1.95
Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer (1993) 1.94
Photoassimilation of acetate and the biosynthesis of amino acids by Chlorobium thiosulphatophilum. Biochem J (1964) 1.94
RR interval variations in young male diabetics. Br Heart J (1975) 1.91
T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med (1998) 1.91
Purification and properties of benzoate-coenzyme A ligase, a Rhodopseudomonas palustris enzyme involved in the anaerobic degradation of benzoate. J Bacteriol (1988) 1.89
Involvement of coenzyme A thioesters in anaerobic metabolism of 4-hydroxybenzoate by Rhodopseudomonas palustris. J Bacteriol (1989) 1.87
Impact of a national campaign on GP education: an evaluation of the Defeat Depression Campaign. Br J Gen Pract (1999) 1.83
Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess (2004) 1.82
Radiographic assessment of patellofemoral osteoarthritis. Ann Rheum Dis (1993) 1.79
A cluster of bacterial genes for anaerobic benzene ring biodegradation. Proc Natl Acad Sci U S A (1997) 1.78
Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet (1983) 1.78
Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol (1987) 1.78
Enzyme flexibility in Drosophila melanogaster. Nature (1970) 1.76
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology (2000) 1.76
Autonomic mechanisms in the initial heart rate response to standing. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.75
TUMORS OF PERIPHERAL NERVES. Ann Surg (1930) 1.73
Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax (2007) 1.73
Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry (2000) 1.71
The ATPase activities of rat cardiac myosin isoenzymes. FEBS Lett (1980) 1.69
Patient comfort during cataract surgery with modified topical and peribulbar anesthesia. J Cataract Refract Surg (1997) 1.69
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax (2006) 1.66
Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease. Tubercle (1980) 1.65
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplant (2005) 1.64
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology (1996) 1.64
Fundus-first laparoscopic cholecystectomy. Surg Endosc (1995) 1.64
Chemical studies on light chains from cardiac and skeletal muscle myosins. Nature (1971) 1.62
Peripheral and autonomic nerve function in diabetic ketoacidosis. Lancet (1976) 1.62
CO2 fixation and its regulation in Anacystis nidulans (Synechococcus). Arch Microbiol (1975) 1.61
Mapping of quantitative trait loci controlling trypanotolerance in a cross of tolerant West African N'Dama and susceptible East African Boran cattle. Proc Natl Acad Sci U S A (2003) 1.60
Suppression of infection by famine and its activation by refeeding--a paradox? Perspect Biol Med (1977) 1.60
Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J Urol (1998) 1.57
Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE. Acta Crystallogr D Biol Crystallogr (2006) 1.56
Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab (1995) 1.56
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Molecular and phylogenetic characterisation of Cryptosporidium from birds. Int J Parasitol (2001) 1.55
Regulation of phosphate accumulation in the unicellular cyanobacterium Synechococcus. J Bacteriol (1979) 1.55
Analysis of multidisciplinary lung cancer practice. Intern Med J (2007) 1.55
A map of the human genome in linkage disequilibrium units. Proc Natl Acad Sci U S A (2005) 1.54
Modulation of nuclear localization of the influenza virus nucleoprotein through interaction with actin filaments. J Virol (1999) 1.54
Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod (2010) 1.54
Sequence of epicardial repolarisation and configuration of the T wave. Br Heart J (1988) 1.53
Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.53
Dendritic cells: On the move from bench to bedside. Nat Med (2001) 1.52
Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs. Br Dent J (2003) 1.52